{"id":"https://openalex.org/W1984847435","doi":"https://doi.org/10.1097/ccm.0b013e3181d16866","title":"Changing trends in the epidemiology of Candida blood stream infections: A matter for concern?*","display_name":"Changing trends in the epidemiology of Candida blood stream infections: A matter for concern?*","alternate_titles":[],"publication_year":2010,"publication_date":"2010-02-12","ids":{"openalex":"https://openalex.org/W1984847435","doi":"https://doi.org/10.1097/ccm.0b013e3181d16866","mag":"1984847435","pmid":"https://pubmed.ncbi.nlm.nih.gov/20168159"},"language":"en","primary_location":{"id":"doi:10.1097/ccm.0b013e3181d16866","doi":"https://doi.org/10.1097/ccm.0b013e3181d16866","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ccm.0b013e3181d16866","pdf_url":null,"source":{"id":"https://openalex.org/S108732581","display_name":"Critical Care Medicine","issn_l":"0090-3493","issn":["0090-3493","1530-0293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Care Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1984847435"],"child_works_count":0,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054286469","display_name":"Jack D. Sobel","orcid":"https://orcid.org/0000-0002-5589-4609","observed_orcids":["https://orcid.org/0000-0002-5589-4609"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. D. Sobel","raw_affiliation_strings":["Detroit, MI","Division of Infectious Diseases","Wayne State University School of Medicine","Dr. Sobel has consulted for Pfizer and Merck","For information regarding this article, E-mail: [email\u00a0protected]","has received grants from Merck","has received speaking fees from Pfizer, Merck, and Astella"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Detroit, MI","institution_ids":[]},{"raw_affiliation_string":"Division of Infectious Diseases","institution_ids":[]},{"raw_affiliation_string":"Wayne State University School of Medicine","institution_ids":["https://openalex.org/I185443292"]},{"raw_affiliation_string":"Dr. Sobel has consulted for Pfizer and Merck","institution_ids":[]},{"raw_affiliation_string":"For information regarding this article, E-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"has received grants from Merck","institution_ids":[]},{"raw_affiliation_string":"has received speaking fees from Pfizer, Merck, and Astella","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5054286469"],"corresponding_institution_ids":["https://openalex.org/I185443292"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"3","first_page":"990","last_page":"992"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11551","display_name":"Infective Endocarditis Diagnosis and Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12668","display_name":"Yeasts and Rust Fungi Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/candida","display_name":"Candida","score":0.7929999828338623},{"id":"https://openalex.org/keywords/bloodstream-infection","display_name":"bloodstream infection","score":0.9660000205039978},{"id":"https://openalex.org/keywords/candidemia","display_name":"candidemia","score":0.6399999856948853},{"id":"https://openalex.org/keywords/epidemiological-trends","display_name":"epidemiological trends","score":0.8009999990463257},{"id":"https://openalex.org/keywords/antifungal-resistance","display_name":"antifungal resistance","score":0.6349999904632568},{"id":"https://openalex.org/keywords/invasive-fungal-infections","display_name":"invasive fungal infections","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8934770822525024},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.720675528049469},{"id":"https://openalex.org/C2993831823","wikidata":"https://www.wikidata.org/wiki/Q11068","display_name":"Blood stream","level":2,"score":0.5615741014480591},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5376400351524353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1395161747932434}],"mesh":[{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002177","descriptor_name":"Candidiasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002177","descriptor_name":"Candidiasis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D003422","descriptor_name":"Critical Care","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015725","descriptor_name":"Fluconazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016469","descriptor_name":"Fungemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016469","descriptor_name":"Fungemia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D025141","descriptor_name":"Drug Resistance, Fungal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D041221","descriptor_name":"Candida glabrata","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/ccm.0b013e3181d16866","doi":"https://doi.org/10.1097/ccm.0b013e3181d16866","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ccm.0b013e3181d16866","pdf_url":null,"source":{"id":"https://openalex.org/S108732581","display_name":"Critical Care Medicine","issn_l":"0090-3493","issn":["0090-3493","1530-0293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Care Medicine","raw_type":"journal-article"},{"id":"pmid:20168159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20168159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical care medicine","raw_type":"Editorial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1979497376","https://openalex.org/W1985706241","https://openalex.org/W2005467096","https://openalex.org/W2054938569","https://openalex.org/W2061823928","https://openalex.org/W2083058613","https://openalex.org/W2106638871","https://openalex.org/W2117166221","https://openalex.org/W2118489318","https://openalex.org/W2129515144","https://openalex.org/W2137575148","https://openalex.org/W2141563676","https://openalex.org/W2150428940","https://openalex.org/W2154371486","https://openalex.org/W2164001967","https://openalex.org/W2171155970"],"related_works":["https://openalex.org/W2052863944","https://openalex.org/W1605698528","https://openalex.org/W6889755736","https://openalex.org/W2131738273","https://openalex.org/W2312495798","https://openalex.org/W2083509061","https://openalex.org/W2332022748","https://openalex.org/W2463037938","https://openalex.org/W174911354","https://openalex.org/W1969114579"],"abstract_inverted_index":{"Division":[0],"of":[1,8],"Infectious":[2],"Diseases;":[3],"Wayne":[4],"State":[5],"University":[6],"School":[7],"Medicine;":[9],"Detroit,":[10],"MI":[11],"Dr.":[12],"Sobel":[13],"has":[14,20,30],"consulted":[15],"for":[16],"Pfizer":[17],"and":[18,27,29],"Merck;":[19],"received":[21,31],"speaking":[22],"fees":[23],"from":[24,33],"Pfizer,":[25],"Merck,":[26],"Astella;":[28],"grants":[32],"Merck.":[34],"For":[35],"information":[36],"regarding":[37],"this":[38],"article,":[39],"E-mail:":[40],"[email":[41],"protected]":[42]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1984847435","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
